Fingerprint
Dive into the research topics of 'A Phase I Trial of IGF-1R Inhibitor Cixutumumab and mTOR Inhibitor Temsirolimus in Metastatic Castration-resistant Prostate Cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A Phase I Trial of IGF-1R Inhibitor Cixutumumab and mTOR Inhibitor Temsirolimus in Metastatic Castration-resistant Prostate Cancer
Deaglan J. McHugh, Jay Chudow, Mia DeNunzio, Susan F. Slovin, Daniel C. Danila, Michael J. Morris, Howard I. Scher, Dana E. Rathkopf
Research output: Contribution to journal › Article › peer-review
20
Scopus
citations